Found 14 matching trials
Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults PHASE1 The purpose of the study is to evaluate the safety, tolerability, and immun...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP PHASE2 This international, multi-centre, double-blind vaccine study is a three-arm...
Show More Location
MRC/UVRI and LSHTM Uganda Research Unit
Learn More & Join Trial
Safety and Immune Response to a Clade C DNA HIV Vaccine PHASE1 The purpose of this study is to evaluate the safety and immune response to ...
Show More Location
Aurum Tembisa CRS
Learn More & Join Trial
A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya PHASE1 This is a study of HIV vaccines. A vaccine is a medical product given to pr...
Show More Location
Kenya Medical Research Institute/Walter Reed Project, Clinical Research Centre, Off Hospital Road
Learn More & Join Trial
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults PHASE1 The purpose of this study is to evaluate the safety of and immune response ...
Show More Location
Rockville Vaccine Assessment Clinic (RVAC)
Learn More & Join Trial
Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults PHASE2 The purpose of the study is to evaluate the safety, tolerability, and immun...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety and immune response to the DNA-HIV-PT12...
Show More Learn More & Join Trial
Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers PHASE1 CUTHIVAC002 is a randomised Phase I study aimed at exploring the safety and...
Show More Location
NIHR/Wellcome Trust Imperial Clinical Research Facility, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Learn More & Join Trial
A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults PHASE1 EHVA P01 is an international, phase I, prophylactic HIV vaccine trial to ev...
Show More Learn More & Join Trial
Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults PHASE1 The purpose of this study is to determine the safety of, immune response to...
Show More Location
Alabama Vaccine CRS
Learn More & Join Trial